Anti-RSV glycoprotein F Therapeutic Antibody (Motavizumab)

Recombinant humanized (from mouse) antibody expressed in CHO binding to RSV glycoprotein F. Motavizumab is a humanized monoclonal antibody for the prevention of respiratory syncytial virus infection in high-risk infants.
Supplier Creative Biolabs
Product # TAB-709
Pricing Inquiry
Host Mouse
Target RSV glycoprotein F
Species Reactivity RSV
Type IgG1 - kappa
Applications IF, IP, Neut, FuncS, ELISA, FC, WB
Storage 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.
Feedback